MedPath

Influence of glycaemic index on day-long glycaemia in type 2 diabetics

Not Applicable
Recruiting
Conditions
Type 2 diabetes
Diet and Nutrition - Other diet and nutrition disorders
Metabolic and Endocrine - Diabetes
Registration Number
ACTRN12613000013763
Lead Sponsor
niversity of Otago
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
22
Inclusion Criteria

Type 2 diabetes

Non insulin users

Exclusion Criteria

Use of insulin
Diagnosis of cardiovascular disease, cancer, or diseases of the gastrointestinal system

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Postprandial and day-long glycaemia as assessed using a continuous glucose monitor[Interstitial glucose measurements taken every 5 minutes for a period of 96 hours. The start time of the monitoring will be at the commencement of the first meal and the end time will occur 3 hours after starting the last meal. ie: monitoring occurs continuously during the entire four day period.]
Secondary Outcome Measures
NameTimeMethod
Reproducibility of repeated day-long glycaemia. Incremental area under the blood glucose curve (iAUC) after each meal and for each day (24 hour period) will be calculated from the continuous monitoring data for each person using the trapezoidal method. [Comparison between two days readings. The group average of the two days low glycaemic index iAUC will be compared with the average iAUC during the high glycaemic index period using repeated measures ANOVA.]
© Copyright 2025. All Rights Reserved by MedPath